NEW YORK (GenomeWeb) – Danaher has completed its roughly $13.8 billion acquisition of Pall, a provider of filtration, separation, and purification products for life sciences and other applications.

Under terms of the merger, each outstanding share of Pall common stock was cancelled and converted into the right to receive $127.20 per share in cash.

The firms inked the deal in May. The $13.8 billion price tag includes assumed debt and is net of acquired cash.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.